120 related articles for article (PubMed ID: 37173220)
1. A Risk-scoring Model for Predicting Post-recurrence Survival in Patients With Endometrial Carcinoma.
Kolehmainen A; Pasanen A; Koivisto-Korander R; Bützow R; Loukovaara M
Clin Oncol (R Coll Radiol); 2023 Jul; 35(7):472-477. PubMed ID: 37173220
[TBL] [Abstract][Full Text] [Related]
2. Risk-stratification of endometrial carcinomas revisited: a combined preoperative and intraoperative scoring system for a reliable prediction of an advanced disease.
Tuomi T; Pasanen A; Luomaranta A; Leminen A; Bützow R; Loukovaara M
Gynecol Oncol; 2015 Apr; 137(1):23-7. PubMed ID: 25643690
[TBL] [Abstract][Full Text] [Related]
3. Adult Comorbidity Evaluation 27 score as a predictor of survival in endometrial cancer patients.
Binder PS; Peipert JF; Kallogjeri D; Brooks RA; Massad LS; Mutch DG; Powell MA; Thaker PH; McCourt CK
Am J Obstet Gynecol; 2016 Dec; 215(6):766.e1-766.e9. PubMed ID: 27457116
[TBL] [Abstract][Full Text] [Related]
4. The prognostic role of preoperative serum CA125 levels in patients with advanced endometrial carcinoma.
Modarres-Gilani M; Vaezi M; Shariat M; Zamani N; Nourizadeh R
Cancer Biomark; 2017 Aug; 20(2):135-141. PubMed ID: 28800309
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Metabolic tumour volume and total lesion glycolysis, measured using preoperative 18F-FDG PET/CT, predict the recurrence of endometrial cancer.
Shim SH; Kim DY; Lee DY; Lee SW; Park JY; Lee JJ; Kim JH; Kim YM; Kim YT; Nam JH
BJOG; 2014 Aug; 121(9):1097-106; discussion 1106. PubMed ID: 24397772
[TBL] [Abstract][Full Text] [Related]
7. A Nomogram for Predicting Progression-free Survival in Patients with Endometrial Cancer.
Wang Z; Zhao Z; Li W; Bao X; Liu T; Yang X
Clin Oncol (R Coll Radiol); 2023 Sep; 35(9):e516-e527. PubMed ID: 37230875
[TBL] [Abstract][Full Text] [Related]
8. Combination of Proactive Molecular Risk Classifier for Endometrial cancer (ProMisE) with sonographic and demographic characteristics in preoperative prediction of recurrence or progression of endometrial cancer.
Eriksson LSE; Nastic D; Lindqvist PG; Imboden S; Järnbert-Pettersson H; Carlson JW; Epstein E
Ultrasound Obstet Gynecol; 2021 Sep; 58(3):457-468. PubMed ID: 33314410
[TBL] [Abstract][Full Text] [Related]
9. HE4 is superior to CA125 in the detection of recurrent disease in high-risk endometrial cancer patients.
Abbink K; Zusterzeel PL; Geurts-Moespot AJ; Herwaarden AEV; Pijnenborg JM; Sweep FC; Massuger LF
Tumour Biol; 2018 Feb; 40(2):1010428318757103. PubMed ID: 29463191
[TBL] [Abstract][Full Text] [Related]
10. Predicting poor prognosis recurrence in women with endometrial cancer: a nomogram developed by the FRANCOGYN study group.
Ouldamer L; Bendifallah S; Body G; Touboul C; Graesslin O; Raimond E; Collinet P; Coutant C; Lavoué V; Lévêque J; Daraï E; Ballester M
Br J Cancer; 2016 Nov; 115(11):1296-1303. PubMed ID: 27824810
[TBL] [Abstract][Full Text] [Related]
11. Estimating the risk of endometrial cancer in symptomatic postmenopausal women: a novel clinical prediction model based on patients' characteristics.
Burbos N; Musonda P; Duncan TJ; Crocker SG; Morris EP; Nieto JJ
Int J Gynecol Cancer; 2011 Apr; 21(3):500-6. PubMed ID: 21436697
[TBL] [Abstract][Full Text] [Related]
12. A risk scoring system to determine recurrence in early-stage type 1 endometrial cancer: a French multicentre study.
Bendifallah S; Canlorbe G; Huguet F; Coutant C; Hudry D; Graesslin O; Raimond E; Touboul C; Collinet P; Bleu G; Daraï E; Ballester M
Ann Surg Oncol; 2014 Dec; 21(13):4239-45. PubMed ID: 24969441
[TBL] [Abstract][Full Text] [Related]
13. Serum HE4 and CA125 combined to predict and monitor recurrence of type II endometrial carcinoma.
Quan Q; Liao Q; Yin W; Zhou S; Gong S; Mu X
Sci Rep; 2021 Nov; 11(1):21694. PubMed ID: 34737393
[TBL] [Abstract][Full Text] [Related]
14. [Establishment of risk evaluation model of peritoneal metastasis in gastric cancer and its predictive value].
Zhao J; Zhou R; Zhang Q; Shu P; Li H; Wang X; Shen Z; Liu F; Chen W; Qin J; Sun Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):47-52. PubMed ID: 28105619
[TBL] [Abstract][Full Text] [Related]
15. A nomogram for predicting recurrence in endometrial cancer patients: a population-based analysis.
Miao M; Zhu Y; Wang L; Miao Y; Li R; Zhou H
Front Endocrinol (Lausanne); 2023; 14():1156169. PubMed ID: 38027107
[TBL] [Abstract][Full Text] [Related]
16. Identification of a Multi-RNA-Type-Based Signature for Recurrence-Free Survival Prediction in Patients with Uterine Corpus Endometrial Carcinoma.
Wang P; Zeng Z; Shen X; Tian X; Ye Q
DNA Cell Biol; 2020 Apr; 39(4):615-630. PubMed ID: 32105510
[TBL] [Abstract][Full Text] [Related]
17. Predicting survival for metastatic spine disease: a comparison of nine scoring systems.
Ahmed AK; Goodwin CR; Heravi A; Kim R; Abu-Bonsrah N; Sankey E; Kerekes D; De la Garza Ramos R; Schwab J; Sciubba DM
Spine J; 2018 Oct; 18(10):1804-1814. PubMed ID: 29567516
[TBL] [Abstract][Full Text] [Related]
18. Developing and validating ultrasound-based radiomics models for predicting high-risk endometrial cancer.
Moro F; Albanese M; Boldrini L; Chiappa V; Lenkowicz J; Bertolina F; Mascilini F; Moroni R; Gambacorta MA; Raspagliesi F; Scambia G; Testa AC; Fanfani F
Ultrasound Obstet Gynecol; 2022 Aug; 60(2):256-268. PubMed ID: 34714568
[TBL] [Abstract][Full Text] [Related]
19. Competing risk nomogram predicting cancer-specific mortality for endometrial cancer patients treated with hysterectomy.
Xie G; Qi C; Yang W; Wang R; Yang L; Shang L; Huang L; Chung MC
Cancer Med; 2021 May; 10(10):3205-3213. PubMed ID: 33932121
[TBL] [Abstract][Full Text] [Related]
20. Preoperative neutrophil-to-lymphocyte, platelet-to-lymphocyte and monocyte-to-lymphocyte ratio as a prognostic factor in non-endometrioid endometrial cancer.
Song H; Jeong MJ; Cha J; Lee JS; Yoo JG; Song MJ; Kim JH; Lee SJ; Lee HN; Yoon JH; Park DC; Kim SI
Int J Med Sci; 2021; 18(16):3712-3717. PubMed ID: 34790044
[No Abstract] [Full Text] [Related]
[Next] [New Search]